Dr. Seungpyo Hong is Milton J. Henrichs Endowed Chair Professor in the Pharmaceutical Sciences Division and Director of Wisconsin Center for NanoBioSystems (WisCNano), School of Pharmacy at the University of Wisconsin-Madison (UW-Madison). He also holds an appointment as Adjunct Professor in the Colleges of Pharmacy at the University of Illinois at Chicago (UIC) and at Yonsei University, Seoul, Korea, along with serving as Associate Editor for Nanomedicine: Nanotechnology, Biology and Medicineof Elsevier. Dr. Hong is also active in entrepreneurship, co-founding a biotech startup Capio Biosciences where he serves as President. He graduated from Hanyang University in Seoul, Korea with B.S. and M.S. degrees in polymer engineering in 1999 and 2001, respectively. After working as a researcher at Korea Institute Science and Technology (KIST), he started his Ph.D. study at the University of Michigan working with his advisors Profs. Mark Banaszak Holl and James Baker, Jr. Dr. Hong graduated with his PhD in Macromolecular Science and Engineering in 2006 and joined MIT as a postdoctoral associate in the laboratory of Prof. Robert Langer. From 2008 to 2014, he was Assistant Professor at UIC where he was promoted to Associate Professor with tenure in 2014, and subsequently joined the UW-Madison faculty as full Professor in 2016. Since 2008, he has led a research group under the major research theme of “Biomimetic Nanotechnology” for cancer treatment. To date, Prof. Hong’s research has culminated in ~90 peer-reviewed articles that have a combined total number of over 14,000 citations, 7 book chapters, and 18 issued or pending patents, while delivering over 140 invited talks worldwide and over 180 conference proceedings.